Contraline — Valuation, Funding & Investors

Recent changes

Jun 10, 2026Jun 10, 2026Raised $55.8M SEC EDGAR Form D

Funding History

1 event · sources dated per row

Date	Event	Amount	Valuation	Investors	Source
Jun 10, 2026	funding round	$55.8M	—		SEC EDGAR Form D

No Value Add Pulse story covers Contraline yet. This profile is built from filings, registries and sourced research — every figure above carries its date and source.

Related Companies

Same sector

Attovia Therapeutics Apnimed Braveheart Bio Latigo Biotherapeutics Scribe Therapeutics

Sources & methodologyshow

Where these figures come from

SEC EDGAR Form Dprimary source1 fact

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction